33 research outputs found

    Verification of electromagnetic effects from wireless devices in operating nuclear power plants

    Get PDF
    Wireless communication technologies, especially smartphones, have become increasingly common. Wireless technology is widely used in general industry and this trend is also expected to grow with the development of wireless technology. However, wireless technology is not currently applied in any domestic operating nuclear power plants (NPPs) because of the highest priority of the safety policy. Wireless technology is required in operating NPPs, however, in order to improve the emergency responses and work efficiency of the operators and maintenance personnel during its operation. The wired telephone network in domestic NPPs can be simply connected to a wireless local area network to use wireless devices. This design change can improve the ability of the operators and personnel to respond to an emergency situation by using important equipment for a safe shutdown. IEEE 802.11 smartphones (Wi-Fi standard), Internet Protocol (IP) phones, personal digital assistant (PDA) for field work, notebooks used with web cameras, and remote site monitoring tablet PCs for on-site testing may be considered as wireless devices that can be used in domestic operating NPPs. Despite its advantages, wireless technology has only been used during the overhaul period in Korean NPPs due to the electromagnetic influence of sensitive equipment and cyber security problems. This paper presents the electromagnetic verification results from major sensitive equipment after using wireless devices in domestic operating NPPs. It also provides a solution for electromagnetic interference/radio frequency interference (EMI/RFI) from portable and fixed wireless devices with a Wi-Fi communication environment within domestic NPPs

    Long-Term Experience of Sperm Cryopreservation in Cancer Patients in a Single Fertility Center

    No full text
    Purpose: Sperm cryopreservation before cancer treatment is the most effective method to preserve the fertility of male pa-tients. We present our 21 years experience with sperm cryopreservation for cancer patients, including an examination of se-men quality, the current status of cryopreserved sperm, and the rate of sperm use for assisted reproductive technology (ART). Materials and Methods: A total of 721 cancer patients at Fertility Center of CHA Gangnam Medical Center successfully per-formed sperm cryopreservation for fertility preservation from January 1996 to December 2016. Medical chart review was used to analyze patient age, marital status, cancer type, semen volume, sperm counts and motility, length of storage, and cur-rent banking status. Results: The major cancers of the 721 patients were leukemia (28.4%), lymphoma (18.3%), testis cancer (10.0%). The mean age at cryopreservation was 27.0 years, and 111 patients (15.4%) performed sperm cryopreservation during or after cancer treatment. The mean sperm concentration was 66.7±66.3 ×106/mL and the mean sperm motility was 33.8%±16.3%. During median follow-up duration of 75 months (range, 1–226 months), 44 patients (6.1%) used their banked sperm at our fertility center for ART and 9 patients (1.2%) transferred their banked sperm to another center. The median duration from cryopreser-vation to use was 51 months (range, 1–158 months). Conclusions: Sperm cryopreservation before gonadotoxic treatment is the most reliable method to preserve the fertility of male cancer patients. Sperm cryopreservation should be offered as a standard of care for all men planning cancer therapy
    corecore